STAT
Recent indexed articles attributed to STAT.
20 matching records currently indexed.
Indexed headlines
1–20 of 20 resultsSTAT+: New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare Advantage
New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare Advantage.
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.
STAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has been struck down in court.
STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NAC
The supplement NAC has been widely available for years, but exists in a legal gray area.
STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
STAT+: NIAID acting head John Powers III appointed as the permanent director
The acting director of NIAID, John Powers III, will become the permanent director, the agency announced Monday.
STAT+: Biotech’s rebound isn’t lifting all boats equally
Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.
STAT+: Suing Joe the Plumber and Microsoft, and diminishing raises
Health care providers turn to the courts to get paid, and how insurance costs are eating your paycheck.
STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more
During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year
Democrats settle on a message: ‘Medicare for More’
It doesn’t have quite the same ring to it as “Medicare for All.” But House Dems have coalesced around a policy priority to expand health care access:
STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.
STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence
CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.
STAT+: Venture capitalist John Doerr says AI company, named for his late brother, could help fix primary care
Venture capitalist John Doerr on Tom Health, a new AI tool for primary care: "I think this is one of the best possible uses of AI."
STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
Versant Ventures, Eli Lilly, and a handful of other investors will pour $100 million into a new startup devoted to solving a thorny gene therapy challenge.
STAT+: With Stephen Miller as chief of staff, Kennedy’s MAHA agenda is reinvigorated
The appointment of Stephen Miller as White House chief of staff has health secretary RFK Jr. invigorated. A top deputy is telling people it's go time for MAHA.
Opinion: Medical school should start after students take the Step 1 exam
“It’s time for a radical reimagining of medical education,” write Rachel Fabi and Amy Caruso Brown.
After difficult two years, medical school group’s leadership isn’t letting its guard down post midterms
After a tumultuous two years entangled in many consequential health and science policy debates, AAMCs isn’t ready to let its guard down.
BeOne, Hengrui top list of China’s most powerful drugmakers
A new STAT-WireScreen index ranks China's most valuable publicly traded biotech companies. See which one topped the list.
Opinion: STAT+: Candles and long baths can’t fix burned-out physicians
The language around self-care for doctors puts the onus on them to fix themselves. But the system is to blame, writes Frances Mei Hardin.
STAT+: Apple and OpenEvidence launch experimental health chat app
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new directions for both companies.